To mitigate risk in new and existing product lifecycles, Chemtiva brings together information on more than 13 million substances, 7 million products and 17,000 suppliers
New York, NY /PRNewswire/ - Elsevier, a global information analytics business specializing in science and health, announced today the launch of Chemtiva, a digital solution designed to enable chemical industry professionals to make more informed decisions across the product lifecycle.
Chemical professionals working in development to production need a variety of data and information to address critical, time-sensitive questions in the decision-making process when bringing new chemicals to market. Chemtiva is the first solution to integrate leading scientific and commercial information into a single platform addressing information and data needs and supporting cross-functional collaboration between R&D, scale-up and EHS (environment, health and safety) functions.
"The global chemical industry invests over $51 billion on R&D1. Faced with greater competition, ever-changing regulatory environments and market pressure to develop more sustainable products, chemical industry professionals must have the right information to make informed decisions and drive efficiencies and profitability," said Bryan Davies, Vice President of Engineering Solutions, Elsevier. "Working closely with industry partners, we developed Chemtiva to help chemical companies make better investment and development decisions so they can bring safer, more profitable products to market faster."
Chemtiva utilizes proprietary domain-specific taxonomies and ontologies and data science technologies to normalize and aggregate must-have information from the global scientific literature, toxicological reports and EHS regulations, with market-relevant information such as global shipments, technical datasheets and industry news, enabling access to over 13 million substances, 7 million products and 17,000 suppliers.
For more information about Chemtiva, please visit its solution page.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com.
1 Sourced from: "The Global Chemistry Industry: Catalyzing Growth and Addressing Our World's Sustainability Challenges" Report for ICCA. Oxford, UK: Oxford Economics. © Oxford Economics Ltd., 2019